logo

Apollo Capital Group, Inc. (APEN)



Trade APEN now with
  Date
  Headline
3/18/2019 8:08:49 AM Apollo Endosurgery Q4 Loss Per Share $0.84 Vs Loss $0.42 Last Year
12/18/2018 8:16:08 AM Apollo Endosurgery Announces Sale Of Its Surgical Product Line To ReShape Lifesciences
10/1/2018 8:10:50 AM Apollo Endosurgery Completes Enrollment In ORBERA Post Approval Study Evaluating ORBERA Intragastric Balloon
6/20/2018 7:02:59 AM Apollo Endosurgery Prices Public Offering Of 3.75 Mln Shares At $5.50/Shr For Gross Proceeds Of $20.6 Mln
6/19/2018 4:06:54 PM Apollo Endosurgery Commences Public Offering Of Common Stock
6/5/2018 9:04:54 AM Apollo Announces Presentation Of Mayo Clinic’s Clinical Study Of ORBERA Intragastric Balloon In Patients With NASH
5/14/2018 5:01:03 AM Apollo Endosurgery Announces Spanish Study Of Endoscopic Sleeve Gastroplasty In NASH Patients